PREVYMIS

This brand name is authorized in Austria, Canada, Croatia, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Spain, Turkey, UK, United States.

Active ingredients

The drug PREVYMIS contains one active pharmaceutical ingredient (API):

1
UNII 1H09Y5WO1F - LETERMOVIR
 

Letermovir inhibits the CMV DNA terminase complex which is required for cleavage and packaging of viral progeny DNA. Letermovir affects the formation of proper unit length genomes and interferes with virion maturation. Letermovir is indicated for prophylaxis of cytomegalovirus (CMV) reactivation and disease.

 
Read more about Letermovir

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 PREVYMIS Film-coated tablet MPI, EU: SmPC European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
J05AX18 J Antiinfectives for systemic use → J05 Antivirals for systemic use → J05A Direct acting antivirals → J05AX Other antivirals
Discover more medicines within J05AX18

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
CA Health Products and Food Branch 02469367, 02469375, 02469383, 02469405
EC Agencia Nacional de Regulación, Control y Vigilancia Sanitaria 7116-MEE-0322, 7118-MEE-0322
EE Ravimiamet 1762523, 1762534, 1762545, 1762556
ES Centro de información online de medicamentos de la AEMPS 1171245001, 1171245002
FI Lääkealan turvallisuus- ja kehittämiskeskus 196318, 529781
FR Base de données publique des médicaments 62944394, 64591854, 67334530, 67601314
GB Medicines & Healthcare Products Regulatory Agency 365798, 388859
HK Department of Health Drug Office 66122, 66123, 66124, 66125
IE Health Products Regulatory Authority 89063, 89064
IL מִשְׂרַד הַבְּרִיאוּת 8529, 8530
IT Agenzia del Farmaco 045890011, 045890023, 045890035, 045890047
JP 医薬品医療機器総合機構 6250048F1027, 6250406A1029
LT Valstybinė vaistų kontrolės tarnyba 1084801, 1084802, 1084803, 1084804
NL Z-Index G-Standaard, PRK 196525, 196533, 196762
NZ Medicines and Medical Devices Safety Authority 20358, 20359, 20360, 20361
PL Rejestru Produktów Leczniczych 100400682, 100400707, 100413489, 100413495
RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale W65647001, W65648001
SG Health Sciences Authority 15757P, 15758P, 15759P
TR İlaç ve Tıbbi Cihaz Kurumu 8699636091463, 8699636091470, 8699636261446, 8699636261453
US FDA, National Drug Code 0006-3075, 0006-3076, 0006-5003, 0006-5004

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.